NMOSD Master Class
Best Clinical Practice in NMO & MOGAD
The field of NMOSD has profoundly evolved scientifically and clinically in the last 17+ years. Patient Health Alliance introduces a new, elevated “NMOSD Master Class” series of presentations of academic-rigor to update non-specialty neurologists on the latest pearls in NMOSD diagnosis, therapeutics and clinical management.
-
Update on Diagnostic Criteria for NMOSD
On the premiere of NMOSD Master Class, Dr. Dean Wingerchuk breaks down an updated perspective of diagnostic criteria for the field of Neuromyelitis optica spectrum disorder (NMOSD).
-
Clinical Evaluation of Vision
On this episode of NMOSD Master Class, Dr. John Chen provides a clinical evaluation of vision and how it pertains to neuromyelitis optica spectrum disorder (NMOSD).
-
Adjudicating Relapses Why and How?
On this episode of NMOSD Master Class, Dr. Benjamin Greenberg from UT Southwestern, provides a critical review of the issues related to adjudicating relapses both in clinic and in clinical trials.
-
Treating Acute Relapses
On this episode of NMOSD Master Class, we will discuss steroids, plasma exchange, and beyond.
-
Switching NMOSD DMTs: Clinical Considerations
On this episode of NMOSD Master Class, Dr. Jeffrey Bennett from the University of Colorado Anschutz Medical Center, addresses issues that may require changes in the selection or sequencing of disease modifying therapies in NMOSD.
-
Emerging Therapies for MOGAD
Many novel treatments are emerging in MOGAD that can help accelerate recovery from attacks and prevent future relapses leading to a lot of hope for improved outcomes in the future for those with MOGAD.
-
Update on Immunizations
Coming Soon Michael Yeaman, PhD, MScProfessor of Medicine, UCLA; Chief, Molecular Medicine, Institute for Infection & Immunity, Harbor-UCLA.
-
Women’s Health Issues
This episode of Master Class will discuss pregnancy management and questions related to women’s health in NMOSD.
-
Update on Biomarkers
This Master Class will provide the latest insights into emerging biomarkers and their clinical implications in NMOSD and MOGAD.
More coming soon…
The Patient Health Alliance (PHA) is a source of information and education for NMOSD and related conditions. The content of the following presentation is based entirely on published data or expert opinion. PHA is not a clinical provider, and does not offer diagnostic, therapeutic or clinical care recommendations or advice on personal health. All patients and caregivers are advised to consult with their healthcare team for specific information.
Supporting Partner
